Clinical Trials Browser

Phase 2 × Pancreatic Cancer Metastatic × Immune Checkpoint Inhibitors × Clear all

NCT07230301 2025-11-17

Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Metastatic